Lack of association of CYP1B1*3 polymorphism and ovarian cancer in a Caucasian population

International Journal of Biological Markers

Volumn 19, Issue 2, 2004, Pages 160-163

  Cecchin, E ^a   Russo, A ^b   Campagnutta, E ^a   Martella, L ^a   Toffoli, Giuseppe ^a  

^a CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

^b Local Health Authority of Milan   (Italy)

Author keywords

CYP1B1*3; Ovarian cancer; Polymorphism

Indexed keywords

4 HYDROXYESTRADIOL; CYTOCHROME P450 1B1; DNA; ESTRADIOL; ESTROGEN; LEUCINE; VALINE; CYTOCHROME P 450 CYP1B1; CYTOCHROME P-450 CYP1B1; UNSPECIFIC MONOOXYGENASE;

ADULT; ALLELE; AMINO ACID SUBSTITUTION; ARTICLE; CANCER RISK; CARCINOGENESIS; CAUCASIAN; CONTROLLED STUDY; ETHNIC DIFFERENCE; FEMALE; FREQUENCY ANALYSIS; GENETIC ANALYSIS; GENETIC POLYMORPHISM; HUMAN; HUMAN TISSUE; HYPOTHESIS; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MOLECULAR INTERACTION; MUTATIONAL ANALYSIS; OVARY CANCER; PERIPHERAL BLOOD MONONUCLEAR CELL; PREVALENCE; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; CHEMISTRY; GENE FREQUENCY; GENETICS; HOMOZYGOTE; METABOLISM; MONONUCLEAR CELL; OVARY TUMOR; RISK; RISK FACTOR;

ALLELES; ARYL HYDROCARBON HYDROXYLASES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENE FREQUENCY; HOMOZYGOTE; HUMANS; LEUCINE; LEUKOCYTES, MONONUCLEAR; ODDS RATIO; OVARIAN NEOPLASMS; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; RISK FACTORS; VALINE;

EID: 4243087007     PISSN: 03936155     EISSN: None     Source Type: Journal    
DOI: 10.1177/172460080401900212     Document Type: Article

References (9)

1. Shimada T, Watanabe J, Kawajiri K, et al. Catalytic properties of polymorphic human cytochrome P450 1B1 variants. Carcinogenesis 1999; 20: 1607-13.
2. Zheng W, Xie DW, Jin F, et al. Genetic polymorphism of cytochrome P450-1B1 and risk of breast cancer. Cancer Epidemiol Biomarkers Prev, 2000; 9: 147-50.
3. Sasaki M, Tanaka Y, Kaneuchi M, Sakuragi N, Dahiya R. CYP1B1 gene polymorphisms have higher risk for endometrial cancer, and positive correlations with estrogen receptor alpha and estrogen receptor beta expressions. Cancer Res, 2003; 63: 3913-8.
4. Scully RE. Tumors of the ovary and maldeveloped gonads, fallopian tube, and broad ligament. In: Young RH and Clement PB, eds. Atlas of Tumor Pathology. Washington DC: Armed Forces Institute of Pathology 1996; 27.
5. Pecorelli S, Odicino F, Maisonneuve P. Carcinoma of the ovary. J Epidemiol Biostat, 1998; 3: 75-80.
6. Hunter RW, Alexander ND, Soutter WP. Meta-analysis of surgery in advanced ovarian carcinoma: is maximum cytoreductive surgery an independent determinant of prognosis? Am J Obstet Gynecol 1992; 166: 504-11.
7. Goodman MT, McDuffie K, Kolonel LN, et al. Case-control study of ovarian cancer and polymorphisms in genes involved in catecholestrogen formation and metabolism. Cancer Epidemiol Biomarkers Prev, 2001, 10: 209-16.
8. Breslow NE, Day NE. Statistical Methods in Cancer Research. Lyon: IARC Scientific Publications, 1980.
9. Bailey LR, Roodi N, Dupont WD, Parl FF. Association of cytochrome P450 1B1 (CYP1B1) polymorphism with steroid receptor status in breast cancer. Cancer Res 1998; 58: 5038-41.